Neurona Therapeutics (Series)
Funding Details
Awarder
Inbox
Date Award
April 3, 2025
Vertical
Biotherapeutics
Funding URL
View Funding Page
Funding Amount
$102,000,000
Company Info
Traction
NRTX-1001 has been well-tolerated and has demonstrated substantial and durable seizure reduction in ongoing Phase 1/2 trials.
Founders
Cory R. Nicholas, Ph.D.
Market
Regenerative cell therapies for neurological disorders
Location
South San Francisco, California, United States
Coinvestors
Fidelity Management & Research Company, The Column Group, Soleus Capital, Viking Global Investors, Cormorant Asset Management, Schroders Capital, LYFE Capital, Euclidean Capital, UCB Ventures, Willett Advisors, UC Investments, YK Bioventures, Berkeley Frontier Fund, Ysios Capital, Alexandria Venture Investments, Spur Capital Partners
Company Description

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

Links
WebsiteCrunchbaseLinkedIn
Back to HomeBack to Biotherapeutics DealsView Funding Announcement